<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03703843</url>
  </required_header>
  <id_info>
    <org_study_id>ARTUS00</org_study_id>
    <nct_id>NCT03703843</nct_id>
  </id_info>
  <brief_title>ARTUS MONO Artificial Urinary Sphincter</brief_title>
  <official_title>Feasibility of ARTUS MONO Artificial Urinary Sphincter Implant in Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Myopowers Medical Technologies France SAS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Myopowers Medical Technologies France SAS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ARTUS MONO implant is an active implantable medical device (AIMD) that assist the
      urethral sphincter function of female patients suffering from moderate to severe urinary
      incontinence, by remotely opening and closing a cuff placed around the bladder neck. The
      purpose of this clinical investigation is to evaluate the feasibility of implantation of the
      device, its safety and its efficacy, when temporarily implanted in female patients scheduled
      for anterior pelvic exenteration for bladder cancer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 23, 2018</start_date>
  <completion_date type="Actual">September 26, 2018</completion_date>
  <primary_completion_date type="Actual">September 26, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bladder catheterization in presence of ARTUS MONO cuff</measure>
    <time_frame>Day 0</time_frame>
    <description>Injection then re-aspiration of 50 cc of saline water through 18 Fr Foley catheter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ARTUS MONO cuff implant</measure>
    <time_frame>Day 0</time_frame>
    <description>Visual analogic scale (from worst to best imaginable easiness and safety)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ARTUS MONO cuff activation</measure>
    <time_frame>Day 0</time_frame>
    <description>Cuff closing to reach 10, 20 and 30% of urethral perimeter reduction</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Urinary Incontinence,Stress</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ARTUS MONO</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ARTUS MONO</intervention_name>
    <description>Temporarily implant and activation of the medical device</description>
    <arm_group_label>Active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female patients aged ≥ 18 yo

          2. BMI &gt; 18,5 and &lt; 35

          3. Patient scheduled for an anterior pelvic exenteration with ileal conduit urinary
             diversion

          4. Signed informed consent

        Exclusion Criteria:

          1. Advanced bladder cancer with bladder neck and/or urethral extension

          2. Past pelvic radiation therapy

          3. Patient previously treated with an artificial urinary sphincter or other urogenital
             implant

          4. Positive urine culture during the past 2 weeks

          5. Indwelling bladder catheter during the past 2 weeks

          6. Documented history of sensitivity to silicone

          7. History of connectivitis disease

          8. Immunosuppressive therapy in the last 3 months

          9. Vulnerable subjects

         10. Participation in any other clinical investigation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas BARRY DELONGCHAMPS, PR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Cochin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Thomayer hospital</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>France</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>May 25, 2018</study_first_submitted>
  <study_first_submitted_qc>October 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2018</study_first_posted>
  <last_update_submitted>October 18, 2018</last_update_submitted>
  <last_update_submitted_qc>October 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AUS</keyword>
  <keyword>Artificial Urinary Sphincter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

